Table 8: Pediatric Insulin Recommended Dosages for Single Insulin Products: Rapid-Acting

Drug Name Dosage Form Approved Age Requirements * Maximum Recommended Dosage *
Insulin aspart
  • Fiasp® vial (100 units/mL – 10 mL)
  • Fiasp® FlexTouch (100 units/mL – 5 x 3 mL)
  • Fiasp® PenFill® cartridges (100 units/mL – 5 x 3 mL) for FlexTouch® device
  • NovoLog® vial (100 units/mL – 10 mL)
  • NovoLog® FlexPen® (100 units/mL – 5 x 3 mL)
  • NovoLog® PenFill® cartridges (100 units/mL – 5 x 3 mL) for NovoPen Echo® device
Children greater than or equal to 2 years and adolescents No maximum recommended dosage to exceed; insulin and other antidiabetic drugs should be adjusted to target glycemic goals and meet patients’ needs
Insulin glulisine
  • Apidra® vial (100 units/mL – 10 mL)
  • Apidra® SoloStar® pen (100 units/mL – 5 x 3 mL)
Children greater than or equal to 4 years and adolescents No maximum recommended dosage to exceed; insulin and other antidiabetic drugs should be adjusted to target glycemic goals and meet patients’ needs
Insulin lispro
  • Admelog® vial (100 units/mL – 3 or 10 mL)
  • Admelog® SoloStar® pen (100 units/mL – 3 mL)
  • HumaLog® cartridges (100 units/mL – 5 x 3 mL) for 
  • HumaPen® Luxura™ HD device
  • HumaLog® vial (100 units/mL – 3 mL)
  • HumaLog® KwikPen® (100 units/mL – 3 mL; 200 units/mL – 3 mL)
Children greater than or equal to 3 years and adolescents No maximum recommended dosage to exceed; insulin and other antidiabetic drugs should be adjusted to target glycemic goals and meet patients’ needs

Legend:

  • No maximum recommended dosage to exceed; insulin and other antidiabetic drugs should be adjusted to target glycemic goals and meet patients’ needs